Sat. November 21, 2009
-
MarketWatch
November 20, 2009
Madrid (marketwatch) -- German pharmaceutical and chemical company
Merck kgaa (FRANKFURT:DE:MRK) was downgraded to hold from buy on
Friday at
Citigroup, ...
Trading Markets (press release)
November 19, 2009
Nov 19, 2009 (Datamonitor via COMTEX) -- MRK | Quote | Chart | News | powerrating -- Merck has reported that in a Phase iib study in 589 patients with ...
Citizens Report
November 19, 2009
Merck, the maker of Zetia, is currently conducting a large study in order to prove that the drug effectively prevents heart attacks and strokes. ...
CNNMoney.com
November 19, 2009
The Abbott-funded "Arbiter 6" study, presented at a major cardiology meeting
Monday, found Niaspan was superior to
Merck & Co.'s (MRK) Zetia at reversing ...
Daily News & Analysis
November 19, 2009
However, British major
GlaxoSmithKline (GSK) and US behemoth
Merck & Co are some of the few companies that have entered into agreements with a ...
Visit Bulgaria
November 19, 2009
In competition with rivals
GlaxoSmithKline and
Merck,
Pfizer is trying to carve a niche for itself in the
global vaccine marketplace. ...
mydigitalfc.com
November 19, 2009
Merck Pharma announced here on
Wednesday the launch of NuvaRing, a product the company claimed to be the world's first vaginal birth control ring. ...
Printed Electronics World
November 19, 2009
Applied Materials, Inc.,
Merck KGaA and the Braunschweig University of
technology (TU-BS) have announced that they have been awarded a grant by
Germany's ...
FiercePharma
November 19, 2009
Merck may be planning to shutter some facilities as it absorbs Schering-Plough. But
the US-based drugmaker is also scouting sites for a "major new facility ...
Reuters
November 19, 2009
FRANKFURT, Nov 19 (Reuters) -
Merck KGaA's (MRCG.DE)
cancer drug Erbitux was again rejected outright by an influential European expert panel on drug ...
Zenopa
November 18, 2009
Merck Sharpe and Dohme has revealed that its therapy Cozaar (iosartan
potassium) has been shown to significantly reduce the risk of death or hospitalisation ...
News-Medical.net
November 18, 2009
In an investigational study,
Merck's medicine COZAAR (losartan
potassium tablets) 150 mg, administered once daily, significantly reduced the risk of ...
RTT News
November 18, 2009
Wal-Mart (WMT) and
Merck (MRK) are also on the rise, advancing by 0.8 percent and 1.2 percent, respectively. Wal-Mart is on pace to close at its highest ...
BNET
November 18, 2009
Merck (MRK) must pay $2.3 billion in
tax following a dispute with the IRS over cash the company parked in the
Caribbean. ...
Trading Markets (press release)
November 18, 2009
The ratings on
Merck are underpinned by its solid footprint as one of the top prescription
pharmaceutical companies in the world and by the limited
debt ...
WELT ONLINE
November 18, 2009
Applied Materials, Inc.,
Merck KGaA and the Braunschweig University of
technology (TU-BS) today announced that they have been awarded a grant by
Germany's ...
RTT News
November 18, 2009
The Merck-sponsored study, called HEAAL or Heart failure Endpoint evaluation of the A-II-Antagonist Losartan, compared the safety and efficacy of two doses ...
Reuters
November 18, 2009
ORLANDO,
Florida (Reuters) - High doses of an experimental heart medicine being developed by
Merck & Co MRK. ...
MarketWatch
November 16, 2009
Merck issued a statement
Sunday criticizing a recent study that questioned the safety and effectiveness of its cholesterol-controlling drugs Vytorin and ...
New York Times
November 12, 2009
analysts are waiting to see whether the new study reinforces the earlier findings or, perhaps, makes matters even worse for
Merck. The study represents the ...
The company recognized revenue on its books related to an up-front payment of $60-million (US) and milestone payment of $15-million from Merck. ...
Merck & Co. (MRK) reiterated its financial targets following the completion of its acquisition of ...
The Dow Jones Industrial Average was recently up 119 points, or 1.2%, at 9891.39, led by a 6% surge in component Merck. The drug maker said it expects ...
Reuters
November 4, 2009
The vaccine is different from the Merck's
Motley Fool
November 4, 2009
Is the new Merck
istockAnalyst.com (press release)
November 4, 2009
Shares of Merck
CNBC
November 4, 2009
Find out why shares of Merck
Reuters
November 4, 2009
Non-GAAP results for fiscal 2009 exclude the recognition of previously deferred revenue totaling approximately $35 million, in connection with Merck
FierceBiotech
November 4, 2009
The $41 billion Merck
Global SMT & Packaging Magazine
November 4, 2009
Merck
Financial.de (Pressemitteilung)
November 4, 2009
Merck
Money Morning
November 3, 2009
Merck
Portfolio.com
November 3, 2009
PharmaLive.com (press release)
November 3, 2009
NuevolutionA/S today announced that it has received a milestone payment derived from its collaboration with Merck
The Ledger
November 3, 2009
The companies say Merck's
Reuters
November 3, 2009
Ms. McGlynn most recently served as President of Vaccines and Infectious
diseases for
Merck
Bizjournals.com
November 3, 2009
As previously announced, the combined company will be known as Merck
Wall Street Journal (blog)
October 30, 2009
We have known Merck
Merck has agreed to sell its interest in Merial Ltd, an animal health business, to its French partner in the joint venture,
Sanofi-Aventis (SASY. ...
Merck has agreed to sell its interest in Merial Ltd, an animal health business, to its French partner in the joint venture,
Sanofi-Aventis (SASY. ...
